There is currently a high demand for value-based pricing of medicines. Pharma providers are thus planning to upscale their digital systems, especially in response to the change in cost dynamics during the COVID-19 pandemic. And through this, pharma companies are looking to secure, aggregate, and analyse the patient data and act on them accordingly to develop more value-based and cost-efficient drugs.
In this regard, advancements in omics data analysis, particularly, are providing new insights into how the human body responds to drugs. Further, technical advancements like AI can are also helping unravel drug efficacy based on age, sex, comorbidities, and other clinical parameters. This knowledge, along with advanced drug development methods such as MIDD, is making personalised medicine a reality. Additionally, such new-age drug exposure models are also helping in determining the pharmacokinetic and pharmacodynamic properties of drugs for arriving at the right dosage.
Amid such trends making a wave in the pharma sector, it is becoming imperative for organisations to equip themselves with the latest and most effective technologies in the market. In order to assist such companies in shoring up their capabilities, we have compiled this issue of Pharma Tech Outlook Europe. In this edition, we have listed the top 10 pharma analytics solution providers in Europe to highlight the ones that can help you escalate your chances of success. Equipped with innovative technological capabilities, these enlisted service providers are transforming the pharma landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject matter experts and CXOs. We hope this issue of Pharma Tech Outlook Europe helps you build the partnership you and your organisation need to foster an environment driven by robust and efficient technology.
We present to you Pharma Tech Outlook Europe’s, “Top 10 Pharma Analytics Solution Providers in Europe – 2021.”
